Viewing StudyNCT04109300



Ignite Creation Date: 2024-05-06 @ 1:43 PM
Last Modification Date: 2024-10-26 @ 1:19 PM
Study NCT ID: NCT04109300
Status: UNKNOWN
Last Update Posted: 2019-09-30
First Post: 2019-09-27

Brief Title: Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease
Sponsor: Western University Canada
Organization: Western University Canada

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-09-01
Start Date Type: ESTIMATED
Primary Completion Date: 2023-09-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-09-01
Completion Date Type: ESTIMATED
First Submit Date: 2019-09-27
First Submit QC Date: September 27 2019
Study First Post Date: 2019-09-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-09-27
Last Update Post Date: 2019-09-30
Last Update Post Date Type: ACTUAL